Literature DB >> 1214290

Respiratory disease mortality in an institutionalised mentally retarded population.

A P Polednak.   

Abstract

Mortality from respiratory diseases has been described in a large institution for the mentally retarded, from 1958 to 1973. Pneumonia continued to account for a large proportion of deaths (around forty per cent), when underlying causes of death were analysed. Age-specific death rates from pneumonia (underlying or contributory cause of death) showed little or no decline for ages five to sixty and over. Autopsy reports on 237 persons revealed high frequencies of bronchopneumonia, pulmonary congestion, pleurisy and aspiration pneumonia. Aspiration and its sequelae (aspiration pneumonia, lipid pneumonia) appears to be a major problem in this population, upon which prevention programmes could concentrate. Some risk factors associated with aspiration were also identified.

Entities:  

Mesh:

Year:  1975        PMID: 1214290     DOI: 10.1111/j.1365-2788.1975.tb01270.x

Source DB:  PubMed          Journal:  J Ment Defic Res        ISSN: 0022-264X


  4 in total

1.  Application of the PRECEDE-PROCEED Planning Model in Designing an Oral Health Strategy.

Authors:  Catherine J Binkley; Knowlton W Johnson
Journal:  J Theory Pract Dent Public Health       Date:  2013-11

2.  Teriparatide is safe and effectively increases bone biomarkers in institutionalized individuals with osteoporosis.

Authors:  Kathryn M Ryder; S Bobo Tanner; Laura Carbone; John E Williams; Henry M Taylor; Andrew Bush; Victorina Pintea; Mitchell A Watsky
Journal:  J Bone Miner Metab       Date:  2009-10-06       Impact factor: 2.626

3.  Risk Factors for Death from Psychiatric Hospital-acquired Pneumonia.

Authors:  Takahiro Haga; Kae Ito; Kentaro Sakashita; Mari Iguchi; Masahiro Ono; Koichiro Tatsumi
Journal:  Intern Med       Date:  2018-03-30       Impact factor: 1.271

4.  Risk factors for pneumonia in patients with schizophrenia.

Authors:  Takahiro Haga; Kae Ito; Kentaro Sakashita; Mari Iguchi; Masahiro Ono; Koichiro Tatsumi
Journal:  Neuropsychopharmacol Rep       Date:  2018-10-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.